HUT76821A - Process for producing carbamazepine medicament with retarded active substance release - Google Patents

Process for producing carbamazepine medicament with retarded active substance release

Info

Publication number
HUT76821A
HUT76821A HU9603565A HU9603565A HUT76821A HU T76821 A HUT76821 A HU T76821A HU 9603565 A HU9603565 A HU 9603565A HU 9603565 A HU9603565 A HU 9603565A HU T76821 A HUT76821 A HU T76821A
Authority
HU
Hungary
Prior art keywords
carbamazepine
pct
medicament
active substance
substance release
Prior art date
Application number
HU9603565A
Other languages
English (en)
Other versions
HU221486B (en
HU9603565D0 (en
Inventor
Karl-Friedrich Landgraf
Sabine Reiss
Eberhard Schubert
Original Assignee
Dresden Arzneimittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dresden Arzneimittel filed Critical Dresden Arzneimittel
Publication of HU9603565D0 publication Critical patent/HU9603565D0/hu
Publication of HUT76821A publication Critical patent/HUT76821A/hu
Publication of HU221486B publication Critical patent/HU221486B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9603565A 1994-07-01 1995-06-22 Process for producing carbamazepine medicament with retarded active substance release HU221486B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de) 1994-07-01 1995-06-22 Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (3)

Publication Number Publication Date
HU9603565D0 HU9603565D0 (en) 1997-02-28
HUT76821A true HUT76821A (en) 1997-11-28
HU221486B HU221486B (en) 2002-10-28

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603565A HU221486B (en) 1994-07-01 1995-06-22 Process for producing carbamazepine medicament with retarded active substance release

Country Status (23)

Country Link
US (1) US5888545A (hu)
EP (1) EP0768882B1 (hu)
JP (1) JPH10502358A (hu)
KR (1) KR100344477B1 (hu)
CN (1) CN1101191C (hu)
AT (1) ATE169818T1 (hu)
BG (1) BG62794B1 (hu)
BR (1) BR9508202A (hu)
CA (1) CA2194216A1 (hu)
CZ (1) CZ288028B6 (hu)
DE (2) DE4423078B4 (hu)
DK (1) DK0768882T3 (hu)
EE (1) EE03954B1 (hu)
ES (1) ES2122630T3 (hu)
GE (1) GEP19991819B (hu)
HU (1) HU221486B (hu)
LT (1) LT4251B (hu)
LV (1) LV11820B (hu)
PL (1) PL180979B1 (hu)
RU (1) RU2141825C1 (hu)
SK (1) SK282303B6 (hu)
UA (1) UA32598C2 (hu)
WO (1) WO1996001112A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
DK0768882T3 (da) 1999-05-25
US5888545A (en) 1999-03-30
KR970703774A (ko) 1997-08-09
LV11820B (en) 1997-12-20
BG101080A (en) 1997-08-29
GEP19991819B (en) 1999-11-05
LT4251B (en) 1997-12-29
CN1101191C (zh) 2003-02-12
WO1996001112A1 (de) 1996-01-18
PL317996A1 (en) 1997-05-12
DE4423078B4 (de) 2005-01-13
UA32598C2 (uk) 2001-02-15
DE4423078A1 (de) 1996-01-04
ES2122630T3 (es) 1998-12-16
PL180979B1 (pl) 2001-05-31
CN1153475A (zh) 1997-07-02
KR100344477B1 (ko) 2002-11-23
BG62794B1 (bg) 2000-08-31
EE03954B1 (et) 2003-02-17
EP0768882B1 (de) 1998-08-19
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
CA2194216A1 (en) 1996-01-18
BR9508202A (pt) 1997-11-11
LT97012A (en) 1997-08-25
EE9600202A (et) 1997-06-16
ATE169818T1 (de) 1998-09-15
CZ288028B6 (cs) 2001-04-11
JPH10502358A (ja) 1998-03-03
SK282303B6 (sk) 2002-01-07
LV11820A (lv) 1997-08-20
HU221486B (en) 2002-10-28
SK164696A3 (en) 1997-06-04
CZ382696A3 (en) 1997-05-14
HU9603565D0 (en) 1997-02-28
RU2141825C1 (ru) 1999-11-27

Similar Documents

Publication Publication Date Title
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
AU8009998A (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
AU7792987A (en) Administration and dosage form for drug active agents, reagents or the like and process for the preparation thereof
IL109770A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
AU1227899A (en) Osmotic medicament releasing system
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
HK12495A (en) Pharmaceutical formulations
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
IL145755A0 (en) Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix
AU1196988A (en) Process for preparing a retard product containing diltiazem for a single daily administration
FI89238B (fi) Foerfarande foer framstaellning av kompressionsbelagda tabletter
HUT76821A (en) Process for producing carbamazepine medicament with retarded active substance release
GR3036407T3 (en) Encapsulated medicine
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
CA2350659A1 (en) Pharmaceutical composition for modified release insulin sensitiser
ZA963893B (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament of diagnostic, and medicament containing them.
CA2210252A1 (en) Crystalline trimetrexate salts and the process for making the same
AU5784096A (en) Method and composition for prevention of posterior capsule opacification
NZ502807A (en) Preparation of solid oral dosage forms of alendronic acid (4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid)
UA66925C2 (uk) Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
HU903510D0 (en) Process for producing 1-phenyl-1,4-dihydro-3-amino-oxopyridazine derivatives and pharmaceutical preparatives containing these compounds as active substance
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
IL122719A (en) Controlled release pharmaceutical dosage forms for oral administration containing nifedipine as active substance and process for their preparation
TH21515A (th) การปลดปล่อยซิซาไพรด์นาน

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: AWD.PHARMA GMBH & CO. KG, DE